cutaneous melanoma: A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.
Benign neoplasm of middle ear and respiratory system
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_EAR_RESP
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2674 |
4. Check minimum number of eventsNone |
2674 |
5. Include endpoints |
3134 |
6. Filter based on genotype QC (FinnGen only) |
3134 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum auris mediae sive systematis respiratorii
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of middle ear and respiratory system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 20664 | 8807 | 11667 |
| Only index persons | 17527 | 7830 | 9697 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.25 | 0.33 |
| Only index persons | 0.33 | 0.29 | 0.37 |
| Median age at first event (years) | |||
| Whole population | 55.29 | 55.15 | 55.31 |
| Only index persons | 53.78 | 53.91 | 53.68 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3134 | 1303 | 1831 |
| Unadjusted period prevalence (%) | 0.66 | 0.44 | 0.81 |
| Median age at first event (years) | 56.26 | 52.93 | 58.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2832
- Matched controls
- 28321
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
4141.2
323.0
907
*
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
+∞
323.0
315
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
9430.0
323.0
1167
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
67.9
323.0
428
74
UDQ22
NOMESCO Finland
Microlaryngoscopy
52.8
230.3
277
58
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.8
217.9
545
835
DHB10
NOMESCO Finland
Excision of lesion of internal nose
134.3
209.7
223
18
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
191.7
206.1
213
12
DHA10
NOMESCO Finland
Biopsy of cavity of nose
56.7
205.4
244
47
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.0
162.8
436
719
DQA10
NOMESCO Finland
Biopsy of larynx
70.9
162.3
186
28
ZXC10
NOMESCO Finland
Use of laser
12.1
132.1
250
225
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
59.3
119.7
141
25
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
+∞
110.1
105
*
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
+∞
103.8
99
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
38.4
103.3
132
36
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
5.9
102.6
309
579
2120A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Nasal cavities, middle ear and accessory sinuses
+∞
89.0
85
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.4
87.8
220
320
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
83.9
938
4848
J38.3
ICD-10 Finland
Other diseases of vocal cords
15.1
82.6
140
97
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.3
77.2
216
365
1420
FHL
Laryngomicroscopy
17.5
75.7
121
72
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
75.6
459
1635
UDM02
NOMESCO Finland
Sinoscopy
8.5
74.9
170
211
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
7.2
74.8
189
277
2123A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung
+∞
72.2
69
*
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
17.2
70.9
114
69
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
70.1
374
1207
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.3
67.9
376
1246
J37.0
ICD-10 Finland
Chronic laryngitis
6.0
65.6
190
335
D14.4
ICD-10 Finland
Benign neoplasm: Respiratory system, unspecified
+∞
63.8
61
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
65.2
60.6
70
11
UDQ02
NOMESCO Finland
Direct laryngoscopy
14.0
59.2
103
76
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.5
58.5
293
894
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
19.7
57.7
88
46
J33.0
ICD-10 Finland
Polyp of nasal cavity
5.5
57.0
176
335
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
55.8
653
3329
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
21.6
54.2
80
38
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
49.1
47
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
22.8
47.6
69
31
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
14.7
47.1
80
56
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
36.3
44.5
57
16
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
52.9
43.7
52
10
UJC01
NOMESCO Finland
Scopy of lower throat
10.0
42.9
87
89
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
41.5
42.6
53
13
R01AD08
ATC
fluticasone; nasal
1.9
42.2
786
4764
H02AB06
ATC
prednisolone; systemic
1.7
41.6
1329
9589
DHB20
NOMESCO Finland
Polypectomy of internal nose
7.2
41.1
102
146
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.1
39.9
162
411
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
39.6
1240
8847
DPA30
NOMESCO Finland
Sphenotomy
13.1
38.4
68
53
J33.8
ICD-10 Finland
Other polyp of sinus
5.4
37.9
118
227
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
37.9
1331
9773
WX402
NOMESCO Finland
General anaesthesia
2.1
37.7
497
2620
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
36.8
200
645
R01AD09
ATC
mometasone; nasal
1.7
36.5
1144
8100
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
81.2
35.9
40
5
DHB40
NOMESCO Finland
Conchotomy
23.6
35.8
51
22
21200
ICD-8 Finland
Benign neoplasm of respiratory system, Cavi nasi
+∞
35.5
34
*
DMB10
NOMESCO Finland
Radical maxillary antrotomy
15.5
35.2
58
38
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.0
35.1
99
169
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
34.7
198
661
21202
ICD-8 Finland
Benign neoplasm of respiratory system, Sinus maxillaris
+∞
34.4
33
*
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
341.1
34.0
34
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
36.3
33.7
43
12
21230
ICD-8 Finland
Benign neoplasm of respiratory system, Bronchus and lung
+∞
33.4
32
*
B977, D141
ICD-10 Finland
NA
+∞
33.4
32
*
GDA20
NOMESCO Finland
Excision of lesion of lung
41.5
33.1
41
10
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.9
32.7
141
378
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
48.1
31.6
38
8
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
53.5
31.3
37
7
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
60.7
31.1
36
6
DQB30
NOMESCO Finland
Laryngectomy
86.1
30.8
34
*
4256
FHL
Nasal or sinus tumor removal
111.3
30.7
33
*
A02BC02
ATC
pantoprazole; systemic
1.6
30.6
1744
14198
WX734
NOMESCO Finland
JET-ventilation
38.5
30.2
38
10
A02BC05
ATC
esomeprazole; systemic
1.6
30.2
1087
7872
D14.2
ICD-10 Finland
Benign neoplasm: Trachea
+∞
28.2
27
*
J31.0
ICD-10 Finland
Chronic rhinitis
2.5
28.1
229
952
ZXA05
NOMESCO Finland
Left side
1.7
27.6
724
4779
R49.0
ICD-10 Finland
Dysphonia
5.6
27.0
80
146
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
62.6
27.0
31
5
J01AA02
ATC
doxycycline; systemic
1.6
26.9
2078
17920
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.4
26.6
99
232
R03AC02
ATC
salbutamol; inhalant
1.5
26.6
1320
10241
WX110
NOMESCO Finland
Local anesthesy
1.5
26.2
1734
14350
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
6.6
25.9
67
103
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.6
25.4
75
137
R01AD12
ATC
fluticasone furoate; nasal
1.7
24.8
678
4506
N02BE01
ATC
paracetamol; systemic, rectal
1.6
24.4
2286
20357
WX002
NOMESCO Finland
Sedation and analgesia
1.7
24.4
543
3401
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
24.3
346
1857
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
6.8
24.1
61
91
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
8.3
23.8
53
65
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
7.4
23.4
56
77
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
23.3
775
5409
DHB00
NOMESCO Finland
Excision of lesion of external nose
6.6
23.3
60
92
R49.01
ICD-10 Finland
Functional dysphonia
3.6
23.0
108
312
DNB40
NOMESCO Finland
Sublabial rhinotomy
+∞
22.9
22
*
B977, D140
ICD-10 Finland
NA
+∞
22.9
22
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
26.1
22.6
31
12
ZXA00
NOMESCO Finland
Right side
1.6
22.6
741
5146
5823
FHL
Lung avobiopsy and wedge resection
121.0
22.6
24
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
22.5
859
6196
J33.9
ICD-10 Finland
Nasal polyp, unspecified
6.2
22.3
60
98
DQB70
NOMESCO Finland
Total excision of vocal cord
52.4
22.1
26
5
J01DB01
ATC
cefalexin; oral
1.5
22.0
2140
18882
N02AX02
ATC
tramadol; systemic, rectal
1.5
22.0
1127
8675
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
80.7
21.7
24
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
21.2
482
3022
R03BB04
ATC
tiotropium bromide; inhalant
1.9
21.2
315
1716
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
34.0
21.1
27
8
R13
ICD-10 Finland
Dysphagia
2.3
21.0
200
900
UDC00
NOMESCO Finland
Ear microscopy
2.2
20.1
214
1015
J38.7
ICD-10 Finland
Other diseases of larynx
10.4
20.1
39
38
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.9
19.9
65
134
R49.08
ICD-10 Finland
Other specified dysphonia
3.9
19.5
82
217
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
19.2
443
2781
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.0
19.2
53
90
J01DA01
ATC
[U] cefalexin; systemic
1.4
19.1
1626
13712
UJC02
NOMESCO Finland
Rigid oesophagoscopy
6.5
19.0
49
76
R06.0
ICD-10 Finland
Dyspnoea
1.6
18.9
630
4366
A02BC01
ATC
omeprazole; systemic
1.5
18.5
716
5134
J38.2
ICD-10 Finland
Nodules of vocal cords
11.5
18.5
34
30
A07AA02
ATC
nystatin; oral
2.3
18.4
183
841
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
18.1
416
2609
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
15.4
17.9
29
19
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
17.7
1143
9091
A02BC03
ATC
lansoprazole; oral
1.5
17.7
753
5507
130
Kela drug reimbursment
Malignant tumour
2.0
17.6
248
1321
ZXA10
NOMESCO Finland
Bilateral
1.6
17.6
477
3131
WF002
NOMESCO Finland
Radical radiotherapy
2.3
17.4
166
748
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
21.0
17.3
25
12
J01CA04
ATC
amoxicillin; systemic
1.4
17.0
2031
18049
R04.0
ICD-10 Finland
Epistaxis
2.0
16.9
214
1092
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
16.8
543
3724
ZXC95
NOMESCO Finland
Use of surgical navigator
5.5
16.6
49
91
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
170.9
16.5
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
16.5
285
1633
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
16.3
490
3295
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
11.2
16.2
30
27
N07BA03
ATC
varenicline; oral
2.4
16.1
141
608
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
15.8
136
581
R07.0
ICD-10 Finland
Pain in throat
2.3
15.8
145
642
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
15.8
646
4663
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
15.8
2308
21143
DHB50
NOMESCO Finland
Turbinoplasty
3.3
15.4
79
247
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
15.4
882
6812
J01FA10
ATC
azithromycin; systemic
1.4
15.3
1334
11097
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.7
15.2
43
76
J34.2
ICD-10 Finland
Deviated nasal septum
2.2
15.2
154
716
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
15.2
551
3871
UGB02
NOMESCO Finland
Tracheoscopy
17.8
15.1
23
13
J01MA12
ATC
levofloxacin; systemic
1.6
15.1
490
3350
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
15.0
534
3737
GB3AV
NOMESCO Finland
NA
25.1
14.7
20
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
14.6
783
5962
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
150.7
14.5
15
*
R04.2
ICD-10 Finland
Haemoptysis
2.6
14.3
108
433
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
14.1
408
2711
GBB00
NOMESCO Finland
Tracheostomy
4.2
13.8
52
126
DPB00
NOMESCO Finland
Partial excision of frontal sinus
23.9
13.8
19
8
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
13.7
143
671
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
13.5
354
2293
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
13.4
91
343
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
13.4
935
7442
N03AX16
ATC
pregabalin; oral
1.5
13.3
558
4031
4509
FHL
Other measure in this category
40.2
13.1
16
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
13.1
127
579
J01FA06
ATC
roxithromycin; oral
1.4
13.1
977
7854
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
13.1
853
6700
UJF32
NOMESCO Finland
Coloscopy
1.4
13.1
650
4858
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
13.0
12.9
22
17
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.4
12.9
61
181
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
12.8
229
1325
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
12.5
142
694
H02AB04
ATC
methylprednisolone; systemic
1.6
12.5
360
2385
DMB40
NOMESCO Finland
Excision of lesion of maxillary antrum trough lateral rhinotomy
+∞
12.5
12
*
R4110
NOMESCO Finland
Physiotherapy
1.4
12.5
645
4850
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
11.7
12.3
22
19
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
7.1
12.3
29
41
J32.1
ICD-10 Finland
Chronic frontal sinusitis
6.4
12.1
31
49
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.7
12.1
51
138
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.7
12.1
40
86
R21
ICPC
Throat symptom/complaint
1.6
12.0
369
2481
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
12.0
477
3406
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
11.9
103
445
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.4
11.9
35
66
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.9
11.9
38
79
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
11.8
188
1048
5822
FHL
Exploratory thoracotomy and small procedure (eg lung suture)
30.1
11.6
15
5
R03BA02
ATC
budesonide; inhalant
1.5
11.6
392
2697
R03DC03
ATC
montelukast; oral
1.6
11.6
347
2317
GBB13
NOMESCO Finland
Revision of tracheostomy
23.0
11.6
16
7
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
3.6
11.5
51
144
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
11.5
417
2910
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
11.1
11.5
21
19
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
11.3
928
7532
N05CF01
ATC
zopiclone; oral
1.4
11.3
796
6306
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
11.3
567
4235
UGC02
NOMESCO Finland
Rigid bronchoscopy
10.6
11.2
21
20
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
9.6
11.2
22
23
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
11.2
928
7538
K02.1
ICD-10 Finland
Caries of dentine
1.3
11.2
1270
10812
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
11.1
1654
14630
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
11.1
874
7039
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
11.1
153
811
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
11.1
115
541
R53
ICD-10 Finland
Malaise and fatigue
1.5
11.1
463
3331
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
8.1
11.1
24
30
R49.09
ICD-10 Finland
Unspecified dysphonia
4.4
10.9
38
87
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
10.8
360
2463
R02
ICPC
Shortness of breath/dyspnoea
1.6
10.8
271
1729
DJA10
NOMESCO Finland
Biopsy of septum of nose
15.5
10.8
17
11
R29
ICPC
Respiratory symptom/complaint other
2.0
10.8
136
697
J01FA09
ATC
clarithromycin; systemic
1.4
10.7
698
5449
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
10.7
205
1213
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
21.5
10.7
15
7
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
12.9
10.6
18
14
1430
FHL
Laryngoscopy (direct)
12.9
10.6
18
14
M54.5
ICD-10 Finland
Low back pain
1.4
10.6
731
5759
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
60.2
10.6
12
*
Z01.2
ICD-10 Finland
Dental examination
1.3
10.5
881
7152
J02AC01
ATC
fluconazole; systemic
1.3
10.5
806
6454
J32.8
ICD-10 Finland
Other chronic sinusitis
11.2
10.5
19
17
DPA20
NOMESCO Finland
Trephine of frontal sinus
9.2
10.5
21
23
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
10.4
293
1925
21299
ICD-8 Finland
Benign neoplasm of respiratory system, Unspecified site
+∞
10.4
10
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.7
10.4
70
265
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
10.4
610
4676
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
10.3
97
437
ZXC99
NOMESCO Finland
Other special technic in surgery
18.8
10.3
15
8
ZXB10
NOMESCO Finland
Medial
5.5
10.2
29
53
AA1AD
NOMESCO Finland
CT of head and brain
1.4
10.2
573
4352
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
23.4
10.2
14
6
R95
ICPC
Chron obstructive pulmonary disease
2.5
10.2
79
324
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
13.1
10.1
17
13
KMAK
NOMESCO Finland
NA
1.3
10.1
1151
9754
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
9.9
131
684
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
26.1
9.8
13
5
ENA10
NOMESCO Finland
Biopsy of pharynx
7.0
9.8
23
33
J01FF01
ATC
clindamycin; systemic
1.4
9.8
629
4890
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
9.7
185
1094
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
55.2
9.6
11
*
R06AE07
ATC
cetirizine; oral
1.3
9.6
946
7841
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
9.6
410
2960
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
15.1
9.5
15
10
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
9.5
492
3683
A02BA02
ATC
ranitidine; systemic
1.4
9.5
479
3569
J39.2
ICD-10 Finland
Other diseases of pharynx
4.8
9.4
30
63
D14
ICD-10 Finland
Benign neoplasm of middle ear and respiratory system
100.3
9.4
10
*
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
100.3
9.4
10
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
9.4
9
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
9.3
131
702
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
10.7
9.3
17
16
J01MA14
ATC
moxifloxacin; systemic
1.6
9.3
213
1331
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.9
9.3
134
724
R01AD01
ATC
beclometasone; nasal
1.5
9.2
341
2392
R08
ICPC
Nose symptom/complaint other
2.4
9.2
74
312
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
9.1
1404
12323
1240
FHL
Bronchoscopy
3.5
9.1
41
119
DMA10
NOMESCO Finland
Exploration of maxillary antrum
15.6
9.0
14
9
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
7.0
9.0
21
30
P01AB01
ATC
metronidazole; oral, rectal
1.3
9.0
878
7253
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
9.0
419
3074
WX400
NOMESCO Finland
Inhalation anesthesy
2.2
9.0
93
440
J38.6
ICD-10 Finland
Stenosis of larynx
24.1
8.9
12
5
R05
ICD-10 Finland
Cough
1.4
8.9
431
3185
M02AA07
ATC
piroxicam; topical
1.3
8.9
869
7183
Z50.5
ICD-10 Finland
Speech therapy
3.5
8.8
40
117
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
8.8
174
1040
N06AX16
ATC
venlafaxine; oral
1.5
8.8
274
1846
B01AB05
ATC
enoxaparin; parenteral
1.3
8.8
706
5670
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.2
8.8
44
139
G47.3
ICD-10 Finland
Sleep apnoea
1.4
8.8
502
3822
J04.0
ICD-10 Finland
Acute laryngitis
2.6
8.8
60
231
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
8.7
314
2184
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
8.7
226
1457
4226
FHL
Posterior radical surgery and possible etmoidectomy
4.2
8.7
31
74
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
8.7
247
1631
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
8.6
1604
14368
R51.80
ICD-10 Finland
Headache
1.5
8.6
289
1980
N05BA01
ATC
diazepam; systemic, rectal
1.5
8.6
313
2183
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
8.6
332
2347
H02AB07
ATC
prednisone; oral
1.5
8.6
343
2443
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
11.6
8.6
15
13
A01AB09
ATC
miconazole; local oral
1.7
8.6
190
1178
R03BA05
ATC
fluticasone; inhalant
1.4
8.5
395
2894
J20
ICD-10 Finland
Acute bronchitis
1.6
8.5
211
1345
DPB10
NOMESCO Finland
Partial excision of sphenoidal sinus
90.3
8.4
9
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
90.3
8.4
9
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
8.4
238
1567
DM1BG
NOMESCO Finland
Paranasal sinuses and face area standard MRI examination with high intensity magnet
+∞
8.3
8
*
21220
ICD-8 Finland
Benign neoplasm of respiratory system, Trachea
+∞
8.3
8
*
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
6.2
8.3
21
34
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
8.3
649
5185
S18
ICPC
Laceration/cut
1.3
8.3
988
8364
J01DA06
ATC
[U] cefuroxime; systemic
1.5
8.3
325
2304
M25.5
ICD-10 Finland
Pain in joint
1.3
8.2
586
4615
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
8.2
239
1585
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
8.2
129
719
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
6.5
8.2
20
31
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
8.1
92
454
GAA31
NOMESCO Finland
Thoracoscopy
6.0
8.1
21
35
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
8.1
399
2952
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
33.4
8.1
10
*
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
4.8
8.1
25
52
N05BA04
ATC
oxazepam; oral
1.4
8.0
528
4103
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.2
8.0
77
356
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
5.9
8.0
21
36
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
7.2
7.9
18
25
R07.3
ICD-10 Finland
Other chest pain
1.6
7.9
207
1336
R06AX22
ATC
ebastine; oral
1.4
7.9
345
2496
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.7
7.9
157
945
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
4.9
7.9
24
49
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.9
7.9
107
567
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.3
7.9
68
299
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
5.1
7.8
23
45
J45
ICD-10 Finland
Asthma
1.6
7.8
200
1285
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
7.8
1232
10772
N02AA05
ATC
oxycodone; systemic
1.4
7.8
346
2515
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
7.7
596
4745
R06AX27
ATC
desloratadine; oral
1.3
7.7
521
4063
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
7.7
118
653
E0000UV
ATC
NA
1.3
7.7
871
7311
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.7
402
3010
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.7
7.6
31
84
M79.1
ICD-10 Finland
Myalgia
1.5
7.6
257
1768
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.6
7.6
202
1312
J32.4
ICD-10 Finland
Chronic pansinusitis
2.9
7.6
42
144
L02
ICPC
Back symptom/complaint
1.6
7.6
172
1073
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.5
387
2887
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.6
7.5
52
203
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.4
472
3648
GDC00
NOMESCO Finland
Lobectomy of lung
4.4
7.4
25
57
C320, 8077, 2
ICD-O-3
NA
80.3
7.4
8
*
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
5.3
7.4
21
40
R09
ICPC
Sinus symptom/complaint
1.7
7.3
134
787
21208
ICD-8 Finland
Benign neoplasm of respiratory system, Nasi, loco multiplici
+∞
7.3
7
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.3
7.3
64
284
UJC12
NOMESCO Finland
Flexible oesophagoscopy
4.2
7.3
26
63
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
7.3
183
1172
D07AC01
ATC
betamethasone; topical
1.3
7.3
770
6399
H01
ICPC
Ear pain/earache
1.6
7.2
195
1271
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
7.2
81
401
XG410
NOMESCO Finland
Flow-volume spirometry
1.9
7.2
100
537
-1
NOMESCO Finland
NA
1.3
7.2
672
5491
4222
FHL
Endonasal etmoidectomy
4.1
7.2
26
64
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
7.2
624
5049
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.7
7.1
29
79
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
7.1
308
2224
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.1
927
7895
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.8
7.1
43
157
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
3.6
7.1
30
85
R03AC12
ATC
salmeterol; inhalant
1.8
7.1
112
628
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
7.1
99
534
N06AB10
ATC
escitalopram; oral
1.4
7.1
374
2803
GDA10
NOMESCO Finland
Biopsy of lung
8.8
7.0
14
16
M79.6
ICD-10 Finland
Pain in limb
1.3
7.0
769
6413
R05
ICPC
Cough
1.3
7.0
448
3462
4239
FHL
Other measure in this category
4.7
7.0
22
47
R96
ICPC
Asthma
1.6
7.0
177
1137
JN4BD
NOMESCO Finland
Extensive body CT
1.5
7.0
255
1783
J01DC02
ATC
cefuroxime; systemic
1.7
7.0
124
723
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
6.9
782
6544
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.6
6.9
178
1147
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.9
167
1061
M01AH05
ATC
etoricoxib; oral
1.2
6.9
1340
11929
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
6.9
224
1525
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
6.8
249
1740
5826
FHL
Lobectomy or bilobectomy
10.9
6.8
12
11
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.8
1238
10940
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.0
6.8
36
121
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
6.1
6.8
17
28
DQW99
NOMESCO Finland
Other operation on larynx
40.1
6.8
8
*
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
40.1
6.8
8
*
R51.81
ICD-10 Finland
Facial pain NOS
2.4
6.7
54
229
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.6
6.7
185
1216
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.7
1036
8989
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.7
535
4275
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
22.6
6.7
9
*
SPAT1301
SPAT
No procedures
1.3
6.7
711
5904
ZXC60
NOMESCO Finland
Application of heat
2.6
6.6
44
169
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
5.5
6.6
18
33
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.3
6.6
54
233
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
6.6
149
929
R01AD11
ATC
triamcinolone; nasal
1.5
6.6
188
1245
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
12.3
6.6
11
9
4252
FHL
Resection, coagulation or cryo on the cortex and nasal mucosa
12.3
6.6
11
9
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.6
240
1678
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
6.5
516
4113
WZC30
NOMESCO Finland
Teaching
1.4
6.5
292
2125
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
10.0
6.5
12
12
J33
ICD-10 Finland
Nasal polyp
4.8
6.5
20
42
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
6.5
205
1388
ELB40
NOMESCO Finland
Partial parotidectomy
3.0
6.5
35
119
A28
ICPC
Limited function/disability NOS
1.4
6.5
328
2438
UJH02
NOMESCO Finland
Anoscopy
1.9
6.5
92
499
C05AA08
ATC
fluocortolone; rectal, topical
1.4
6.5
308
2266
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.9
6.4
88
472
M48.0
ICD-10 Finland
Spinal stenosis
1.4
6.4
277
2001
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.9
6.4
37
129
DM1CD
NOMESCO Finland
Very extensive CT of paranasal sinuses and face area
70.0
6.4
7
*
23130
ICD-8 Finland
Neoplasm of unspecified nature of respiratory organs, Bronchus and lung
70.0
6.4
7
*
G44.2
ICD-10 Finland
Tension-type headache
1.5
6.4
248
1752
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
6.4
126
758
C07AB07
ATC
bisoprolol; oral
1.2
6.4
1150
10125
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.4
649
5356
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
6.3
65
311
GD6AD
NOMESCO Finland
CT of chest and neck
8.2
6.3
13
16
M01AB05
ATC
diclofenac; systemic, rectal
1.2
6.3
1584
14434
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.3
1146
10100
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
6.3
235
1651
J01
ICD-10 Finland
Acute sinusitis
1.9
6.3
90
489
21209
ICD-8 Finland
Benign neoplasm of respiratory system, Nasi, NUD
+∞
6.2
6
*
DQB00
NOMESCO Finland
Excision of lesion of larynx
+∞
6.2
6
*
N06AX11
ATC
mirtazapine; oral
1.3
6.2
680
5655
J47
ICD-10 Finland
Bronchiectasis
2.5
6.2
45
182
A06AD11
ATC
lactulose; oral
1.4
6.2
336
2529
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
6.2
80
421
M54.2
ICD-10 Finland
Cervicalgia
1.6
6.2
137
854
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.3
6.1
28
85
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
6.1
113
667
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
6.1
126
768
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
12.5
6.1
10
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
6.1
63
303
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
6.0
388
3001
R03AC03
ATC
terbutaline; inhalant
1.4
6.0
285
2096
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
6.7
6.0
14
21
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
6.0
670
5580
R06.5
ICD-10 Finland
Mouth breathing
1.5
6.0
189
1280
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.0
580
4748
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
1569
9850
2.19
98.22
2.7
2.1
—
—
—
0
0
(4035726)
425
2186
2.09
39.35
1.5
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
514
2966
1.88
33.83
1.9
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1448
11081
1.57
32.53
4.9
4.9
g/l
35.2
35.3
0.23
1340
10312
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2261
19462
1.58
27.84
8.5
7.6
u/l
80.7
79.1
0.52
2137
18359
(3013650) Neutrophils [#/volume] in Blood by Automated count
1763
14395
1.51
27.53
8.9
9.0
e9/l
4.3
4.2
1.18
1524
12567
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1466
11539
1.51
27.17
6.4
6.1
mmol/l
1.2
1.2
0.06
1369
10443
(3042936) Bacteria identified in Isolate by Culture
577
3658
1.71
27.08
2.1
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
528
3271
1.74
26.92
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1555
12409
1.50
26.84
6.2
5.8
e9/l
0.0
0.0
0.04
1318
10720
(3002582) Erythrocytes [#/volume] in Urine
1060
7825
1.54
26.39
3.6
3.3
e6/l
156.8
88.9
0.33
811
6068
(3001604) Monocytes [#/volume] in Blood
1544
12354
1.49
25.97
6.1
5.8
e9/l
0.6
0.6
1.39
1307
10662
(42870588) Differential panel, method unspecified - Blood
1138
8556
1.52
25.89
5.8
5.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1590
12812
1.49
25.73
6.4
6.1
e9/l
0.2
0.2
0.06
1383
11224
(3019198) Lymphocytes [#/volume] in Blood
1576
12680
1.49
25.68
6.2
5.9
e9/l
1.9
1.9
0.17
1365
11155
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1633
13279
1.48
24.92
6.4
6.3
umol/l
12.0
11.8
0.10
1552
12629
(3006504) Eosinophils/100 leukocytes in Blood
1456
11612
1.47
24.29
6.5
6.1
%
2.9
2.9
0.05
1360
10819
(3018095) Leukocytes [#/volume] in Urine
1176
8994
1.49
24.19
4.1
3.8
e6/l
67.9
108.2
1.35
853
6505
(3019069) Monocytes/100 leukocytes in Blood
1457
11660
1.47
23.65
6.7
6.4
%
8.8
8.8
0.18
1369
10913
(3002030) Lymphocytes/100 leukocytes in Blood
1484
11935
1.46
23.38
6.6
6.2
%
26.8
27.2
0.80
1382
11107
(3030467) Casts [#/volume] in Urine by Automated count
966
7142
1.51
23.21
3.4
3.2
e6/l
0.4
0.4
0.48
715
5440
(3022096) Basophils/100 leukocytes in Blood
1415
11292
1.46
23.13
6.4
6.1
%
0.7
0.7
0.49
1322
10536
(3018418) pH of Serum or Plasma
1006
7522
1.50
22.80
4.2
4.0
ph
7.4
7.4
0.08
216
1467
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1556
12694
1.45
22.35
7.4
6.9
mmol/l
1.2
1.2
0.05
1300
10687
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
101
347
2.97
22.33
1.2
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
189
885
2.21
21.94
2.4
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1450
11723
1.44
21.58
4.2
4.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1452
11753
1.44
21.41
6.4
6.0
%
57.9
57.6
0.35
1358
10994
(3013826) Glucose [Moles/volume] in Serum or Plasma
1785
15036
1.43
20.97
5.5
4.9
mmol/l
6.7
6.8
1.12
1704
14148
(3013707) Erythrocyte sedimentation rate by Westergren method
2106
18328
1.45
20.48
4.6
4.0
mm/h
13.3
12.5
1.26
1966
16948
(36304419) Bacteria [Presence] in Urine
928
6957
1.47
20.25
3.4
3.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
872
6460
1.48
20.19
4.3
4.0
%
88.9
87.7
0.67
854
6297
(3044889) 12 lead EKG panel
2048
17766
1.44
19.98
4.4
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1328
10699
1.42
19.46
10.2
10.0
inr
1.3
1.3
0.74
396
3039
(3000850) Epithelial cells [#/volume] in Urine
747
5484
1.48
17.73
2.8
2.6
e6/l
4.5
4.9
0.51
632
4824
(3012095) Magnesium [Moles/volume] in Serum or Plasma
599
4215
1.52
17.46
4.4
3.3
mmol/l
0.8
0.8
1.31
562
3948
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
435
2866
1.60
16.94
2.5
2.8
umol/l
8.8
8.6
0.04
377
2529
(3023368) Bacteria identified in Blood by Culture
944
7311
1.42
16.63
4.6
4.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
129
579
2.28
16.62
1.7
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
441
2956
1.57
15.90
1.6
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1864
16232
1.37
15.60
5.2
4.5
e6/l
1060.9
1403.2
0.14
30
247
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
644
4699
1.47
15.50
2.8
3.1
mmol/l
2.5
2.5
0.23
553
4140
(3023419) Bacteria identified in Sputum by Culture
88
345
2.60
15.25
2.2
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1005
7978
1.38
14.97
2.5
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1317
10932
1.35
14.71
11.2
9.8
e9/l
0.0
0.0
1.55
1059
8963
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
456
3142
1.53
14.45
7.5
7.5
kpa
5.2
5.1
0.68
442
2987
(3027801) Oxygen [Partial pressure] in Arterial blood
456
3142
1.53
14.45
7.5
7.5
kpa
12.4
12.1
0.66
440
2987
(3003396) Base excess in Arterial blood by calculation
451
3138
1.51
13.60
7.6
7.5
mmol/l
1.4
1.1
0.88
363
2446
(40758558) Short blood count panel - Blood
813
6319
1.39
13.50
7.0
6.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
562
4097
1.45
13.39
3.3
3.0
e6/l
2.2
1.9
0.30
301
2258
(3026782) Osmolality of Urine
676
5116
1.41
13.08
3.0
2.8
mosm/kgh2o
550.0
556.0
0.29
570
4339
(3015377) Calcium [Moles/volume] in Serum or Plasma
1040
8459
1.34
12.79
3.3
3.4
mmol/l
2.4
2.4
0.36
925
7372
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
990
7993
1.35
12.79
2.7
2.6
u/l
56.6
58.6
0.80
923
7380
(3002385) Erythrocyte distribution width [Ratio]
2228
20239
1.35
12.47
21.7
18.2
%
13.8
13.7
2.22
2196
19761
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2036
18268
1.33
12.29
4.2
3.8
pmol/l
14.9
14.9
0.21
1846
16507
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
395
2731
1.51
12.21
4.1
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
587
4382
1.42
12.18
3.1
2.8
e6/l
0.9
1.0
0.55
327
2530
(3016502) Oxygen saturation in Arterial blood
406
2831
1.50
12.04
7.8
7.9
%
95.6
95.5
0.15
395
2716
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
233
1430
1.68
11.94
9.7
10.0
mmol/l
24.8
24.3
1.49
221
1336
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2640
24711
1.43
11.85
19.5
15.1
mg/l
24.3
25.1
0.68
2262
19739
(3000991) Gas panel - Venous blood
332
2226
1.55
11.82
8.8
8.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
85
374
2.31
11.57
2.4
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
572
4299
1.40
11.35
2.0
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1233
10441
1.30
10.92
2.0
2.0
pmol/l
95.7
94.2
0.49
647
5524
(3037467) Urinalysis macro (dipstick) panel - Urine
1896
16976
1.30
10.89
4.8
4.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
370
2595
1.48
10.62
8.5
8.4
g/l
121.8
122.1
0.10
361
2498
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
422
3038
1.45
10.59
3.6
4.3
u/l
249.6
245.4
0.19
403
2869
(3005719) IgG [Mass/volume] in Serum or Plasma
283
1876
1.56
10.58
2.4
2.7
g/l
10.3
10.6
0.47
260
1712
(40768797) Stomach Pathology biopsy report
471
3462
1.42
10.55
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
324
2218
1.51
10.46
2.6
2.2
nmol/l
361.2
370.9
0.31
312
2023
(3018677) aPTT in Platelet poor plasma by Coagulation assay
539
4064
1.39
10.42
2.1
2.1
s
30.4
30.0
0.73
526
3944
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
981
8098
1.31
10.38
3.4
3.2
u/l
34.3
36.3
0.30
935
7688
(3019550) Sodium [Moles/volume] in Serum or Plasma
2719
25714
1.43
10.35
21.6
17.6
mmol/l
139.5
139.7
2.55
2681
25048
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2401
22261
1.34
10.33
5.1
4.6
mu/l
1.9
2.1
1.16
2204
20229
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
150
848
1.81
10.29
1.8
1.5
titre
126.7
259.5
—
6
42
(3000492) Spirometry study
337
2346
1.49
10.02
1.6
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
231
1480
1.61
10.00
9.3
10.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
768
6163
1.33
9.87
2.4
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1607
14186
1.27
9.87
2.9
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2719
25782
1.41
9.56
21.8
17.7
mmol/l
4.0
4.0
1.29
2677
25080
(3009445) Proteinase 3 Ab [Units/volume] in Serum
178
1082
1.68
9.48
2.1
1.5
u/ml
12.5
20.6
—
10
27
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2499
23393
1.34
9.44
17.3
14.1
ml/min/173m2
80.0
79.1
1.36
2146
19400
(3022217) INR in Platelet poor plasma by Coagulation assay
480
3606
1.39
9.42
24.5
26.4
inr
1.4
1.4
0.26
92
513
(3028026) IgM [Mass/volume] in Serum or Plasma
227
1479
1.58
9.16
1.6
1.9
g/l
1.4
1.4
0.05
209
1351
(3014576) Chloride [Moles/volume] in Serum or Plasma
451
3378
1.39
8.99
7.5
7.1
mmol/l
104.3
104.3
0.09
443
3298
(3012501) Base excess in Blood by calculation
114
621
1.87
8.85
3.1
4.9
mmol/l
2.5
2.6
0.11
76
424
(3052851) Hemolysis interference index of Serum or Plasma
133
761
1.78
8.81
3.3
3.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
114
623
1.86
8.77
1.2
1.2
—
—
—
0
0
(4010399)
263
1789
1.51
8.74
1.5
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
177
2.62
8.43
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
671
5392
1.31
8.36
1.9
1.8
mg/l
1.3
1.3
0.07
538
4144
(3014111) Lactate [Moles/volume] in Serum or Plasma
328
2354
1.44
8.32
7.8
7.3
mmol/l
1.3
1.4
0.69
316
2266
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1171
10100
1.25
8.24
3.1
2.8
ug/l
143.9
146.1
0.07
1104
9283
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
327
2354
1.43
8.15
2.5
2.5
u/l
34.0
59.3
0.67
267
2026
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
642
5146
1.31
8.13
4.2
3.8
ng/l
329.9
601.9
0.79
495
4158
(3003458) Phosphate [Moles/volume] in Serum or Plasma
455
3482
1.36
7.89
5.3
5.9
mmol/l
1.1
1.0
0.47
423
3242
(46235355) HIV 1 and 2 tests - Meaningful Use set
451
3449
1.36
7.86
1.7
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
659
5326
1.30
7.82
4.7
4.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
459
3527
1.35
7.75
2.6
2.6
%
21.3
23.0
1.80
403
3024
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
930
7857
1.26
7.71
2.2
2.2
u/l
209.1
239.0
0.52
882
7369
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
396
2981
1.38
7.61
2.0
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2752
26326
1.37
7.60
21.9
17.6
umol/l
81.2
80.7
0.25
2752
26316
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2750
26322
1.37
7.40
12.1
10.6
u/l
26.7
27.0
0.30
2674
25348
(3022948) Iron [Moles/volume] in Serum or Plasma
514
4044
1.32
7.38
2.5
2.5
umol/l
12.0
13.0
2.67
482
3760
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1137
9867
1.24
7.35
2.4
2.2
nmol/l
76.7
77.5
0.42
1025
8793
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
260
1829
1.46
7.33
1.8
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
393
2979
1.37
7.23
2.0
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1351
11957
1.23
7.21
3.9
3.6
estimate
0.0
0.0
0.00
290
2227
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
314
2294
1.41
7.21
3.0
2.9
ng/l
291.7
208.6
0.58
289
2089
(3010421) pH of Blood
123
731
1.71
7.19
3.0
4.6
ph
7.4
7.4
0.70
112
611
(3004789) Transferrin [Mass/volume] in Serum or Plasma
479
3751
1.33
7.09
2.5
2.5
g/l
2.3
2.3
0.44
452
3488
(40761536) Microorganisms panel - Urine sediment
291
2104
1.42
7.09
3.8
4.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
63
305
2.09
6.92
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
125
755
1.68
6.90
1.6
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1349
11975
1.22
6.89
5.2
4.9
estimate
0.0
0.0
0.50
298
2270
(3014007) Fractional oxyhemoglobin in Arterial blood
245
1725
1.46
6.89
9.7
9.5
%
94.0
93.8
0.27
245
1717
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
63
306
2.08
6.87
1.3
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
772
6455
1.26
6.86
2.4
2.2
mg/l
3.1
3.0
0.35
676
5483
(3009261) Glucose [Presence] in Urine by Test strip
1363
12122
1.22
6.80
4.0
3.7
estimate
0.0
0.0
1.34
282
2167
(3048689) Calprotectin [Mass/mass] in Stool
356
2682
1.37
6.80
2.4
2.3
ug/g
152.0
149.6
0.04
276
2130
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1140
9961
1.23
6.76
4.4
3.8
ng/l
90.9
52.7
0.32
815
7144
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
442
3447
1.33
6.72
1.6
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
92
515
1.81
6.64
3.2
3.7
%
58.5
58.3
0.04
92
515
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
903
7710
1.24
6.63
3.2
3.1
ng/l
1233.0
1594.6
2.57
788
6614
(3019060) Gas panel - Arterial blood
258
1848
1.43
6.62
4.0
4.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
244
1730
1.45
6.62
9.7
9.4
%
0.7
0.7
0.16
244
1715
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
47
206
2.30
6.60
2.1
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
544
4380
1.29
6.54
1.5
1.5
g/l
2.6
2.6
0.01
346
2703
(3037522) Nuclear Ab [Titer] in Serum
400
3092
1.34
6.46
1.4
1.3
titre
520.8
502.8
0.08
96
660
(1616796) Gas panel - Central venous blood
104
610
1.73
6.42
3.0
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2528
24043
1.27
6.22
5.0
4.7
mmol/l
6.0
6.0
0.26
2328
21798
(3009542) Hematocrit [Volume Fraction] of Blood
2356
22234
1.24
6.18
19.1
16.1
%
40.0
39.8
0.63
1649
15462
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
59
292
2.04
6.16
3.2
3.3
nmol/l
7.9
24.0
0.40
59
286
(40761511) CBC panel - Blood by Automated count
2671
25598
1.29
6.03
17.2
14.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
199
1383
1.47
6.01
1.4
1.3
u/ml
195.2
217.6
0.19
185
1269
(3027945) Reticulocytes/100 erythrocytes in Blood
396
3090
1.32
5.98
2.3
2.5
%
1.9
1.8
0.84
368
2743
(3022145) Colonoscopy Study observation
359
2773
1.33
5.82
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
56
278
2.03
5.82
4.9
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1745
16051
1.20
5.69
3.4
3.2
u/l
54.9
53.3
0.22
1633
14889
(3028626) Oxygen [Partial pressure] in Capillary blood
103
625
1.67
5.65
4.5
3.1
kpa
7.5
8.0
2.23
97
574
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
37
164
2.27
5.14
1.3
1.3
u/ml
0.4
0.8
0.42
21
81
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
213
1547
1.40
5.10
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
799
6894
1.21
5.09
3.0
2.7
umol/l
6086.1
5423.7
0.14
689
5961
(3013512) EKG study
865
7527
1.21
5.04
4.4
4.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
177
1252
1.44
4.92
4.7
4.0
mmol/l
24.1
24.2
0.12
166
1125
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2416
23027
1.21
4.90
6.3
6.0
mmol/mol
40.2
40.2
0.06
2246
21239
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
55
291
1.91
4.83
1.4
1.3
nmol/l
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
73
423
1.74
4.79
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
276
2114
1.34
4.76
3.8
3.9
mmol/l
1.2
1.2
0.22
250
1851
(3002179) Metamyelocytes/100 leukocytes in Blood
255
1932
1.35
4.73
3.5
4.0
%
0.5
0.6
0.27
69
463
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
54
287
1.90
4.69
1.5
1.4
pmol/l
214.2
322.8
1.56
40
223
(40767503) Oxygen content in Capillary blood by calculation
92
572
1.63
4.66
2.8
2.5
%
15.8
16.1
0.20
39
294
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
35
160
2.20
4.55
1.4
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
276
2129
1.33
4.54
3.7
4.1
%
0.7
0.8
0.34
98
651
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
361
2889
1.28
4.52
1.5
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
33
148
2.24
4.50
2.5
3.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
753
6530
1.20
4.48
4.4
4.0
estimate
0.0
0.0
1.28
279
2161
(3011397) Hemoglobin [Presence] in Urine by Test strip
666
5709
1.21
4.47
4.0
3.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
173
1242
1.42
4.46
1.7
1.8
g/l
1.7
1.5
1.18
146
1068
(3007461) Platelets [#/volume] in Blood
2815
27340
1.29
4.46
27.5
22.0
e9/l
247.2
245.4
0.69
2763
26603
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
456
3763
1.25
4.41
1.3
1.2
u/ml
12.5
13.9
0.14
143
1458
(3002032) Base excess in Venous blood by calculation
314
2476
1.30
4.41
4.1
3.7
mmol/l
1.8
2.0
0.33
264
1983
(3051611) Lipemic interference index of Serum or Plasma
48
251
1.93
4.39
2.9
3.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
2815
27348
1.29
4.39
27.4
22.0
fl
91.1
91.3
1.14
2789
26903
(3026361) Erythrocytes [#/volume] in Blood
2815
27351
1.29
4.36
27.5
22.0
e12/l
4.5
4.5
0.16
2751
26533
(3011985) Renin [Units/volume] in Plasma
56
309
1.83
4.36
1.6
1.4
mu/l
47.8
86.8
0.56
45
277
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
211
1574
1.37
4.34
1.9
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2815
27356
1.29
4.32
27.6
22.1
e9/l
7.0
6.8
4.15
2751
26531
(3000963) Hemoglobin [Mass/volume] in Blood
2815
27356
1.29
4.32
27.7
22.2
g/l
135.0
135.9
2.24
2789
26909
(3026008) Bacteria identified in Urine by Culture
831
7296
1.19
4.28
3.5
3.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
2814
27349
1.28
4.28
27.4
21.9
pg
30.3
30.4
2.91
2788
26901
(3017143) Hepatitis C virus Ab [Presence] in Serum
314
2486
1.29
4.28
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
154
1092
1.43
4.27
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
314
2488
1.29
4.25
4.0
3.7
kpa
5.9
5.9
0.13
304
2409
(40768795) Lymph node Pathology biopsy report
45
233
1.94
4.25
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
474
3949
1.24
4.20
1.3
1.3
iu/ml
41.2
35.4
0.23
132
1251
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
98
638
1.55
4.13
2.2
2.0
mg/l
9.7
11.3
1.45
93
585
(3021440) Promyelocytes/100 leukocytes in Blood
260
2017
1.32
4.13
3.8
4.2
%
0.1
0.1
0.10
92
601
(3047181) Lactate [Moles/volume] in Blood
124
851
1.48
4.09
5.7
6.5
mmol/l
1.2
1.3
1.52
114
744
(3021879) Hepatitis B virus core Ab [Presence] in Serum
214
1617
1.35
4.07
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
99
651
1.54
4.01
1.2
1.2
titre
43.0
87.4
—
10
57
(3021901) Oxygen saturation in Capillary blood
82
518
1.60
3.95
3.3
2.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
223
1704
1.33
3.94
4.8
3.6
kpa
5.2
5.1
0.91
209
1578
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
101
670
1.52
3.93
2.8
3.4
mg/l
1.5
1.6
1.03
95
611
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
213
1618
1.34
3.92
4.5
3.6
mmol/l
2.0
1.8
0.32
163
1184
(3014765) Yersinia sp identified in Stool by Organism specific culture
104
695
1.51
3.92
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
243
1882
1.32
3.91
3.9
4.2
%
0.0
0.5
1.19
77
492
(3023520) Reticulocytes [#/volume] in Blood
291
2310
1.29
3.90
2.5
2.6
e9/l
74.9
69.1
1.78
221
1769
(3003338) MCHC [Mass/volume]
2169
20619
1.17
3.90
23.9
19.5
g/l
332.0
332.6
2.47
2159
20442
(3019309) Folate [Moles/volume] in Red Blood Cells
577
4944
1.20
3.86
1.8
1.8
nmol/l
1166.9
1168.0
0.01
454
3743
(42529406) Shigella sp [Presence] in Stool by Culture
104
699
1.50
3.82
1.2
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
24
101
2.39
3.81
2.2
1.7
nmol/l
3.3
9.0
0.66
19
86
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
101
2.39
3.81
2.7
2.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
225
1731
1.32
3.81
6.5
6.9
mmol/l
24.8
24.5
0.51
215
1612
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
103
692
1.51
3.79
1.2
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
30
140
2.15
3.76
3.8
3.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
104
703
1.50
3.73
1.4
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
87
568
1.55
3.66
2.9
3.0
—
—
—
0
0
(3039000) Anion gap in Blood
93
618
1.52
3.62
5.7
7.3
mmol/l
11.4
11.3
0.08
86
546
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
748
6593
1.18
3.61
1.6
1.7
mmol/l
1.4
1.4
0.91
610
5509
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
359
1.68
3.60
2.0
1.6
g/l
0.9
0.9
0.06
44
270
(3018572) Chloride [Moles/volume] in Blood
93
619
1.52
3.60
5.8
7.3
mmol/l
105.0
105.2
0.15
86
547
(4062490)
42
226
1.87
3.59
1.8
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
96
645
1.50
3.56
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
217
1682
1.31
3.50
4.7
3.6
ph
7.4
7.4
1.94
29
215
(3020779) Urea [Moles/volume] in Serum or Plasma
304
2461
1.26
3.49
7.0
7.5
mmol/l
9.8
10.2
0.39
290
2339
(3035637) Corticotropin [Mass/volume] in Plasma
50
289
1.74
3.41
1.7
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
74
476
1.57
3.35
1.3
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
41
225
1.83
3.32
1.8
1.3
g/l
6.8
6.9
0.01
27
153
(3024139) IgG subclass 3 [Mass/volume] in Serum
41
225
1.83
3.32
1.8
1.3
g/l
0.4
0.4
0.35
27
153
(3028192) IgG subclass 2 [Mass/volume] in Serum
41
225
1.83
3.32
1.8
1.3
g/l
3.3
3.0
0.43
27
153
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
40
219
1.84
3.27
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
219
1718
1.30
3.25
1.9
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
47
272
1.74
3.21
1.3
1.3
mosm/kgh2o
284.9
279.1
0.86
40
199
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
72
468
1.55
3.14
1.6
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
299
2450
1.24
3.11
2.7
2.2
g/l
0.2
0.2
0.15
283
2285
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
275
1.72
3.10
1.1
1.1
u/ml
0.4
3.6
2.17
15
64
(3045414) Leukocytes [Presence] in Urine
149
1115
1.35
3.09
1.8
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
292
2391
1.24
3.06
2.5
2.4
ug/l
8.8
7.9
0.14
262
2108
(44813793)
28
139
2.02
3.05
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
87
594
1.48
3.03
2.0
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
86
586
1.48
3.03
2.2
2.1
g/l
130.9
128.6
0.29
60
424
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
175
1348
1.32
2.99
2.9
3.3
pmol/l
4.4
4.5
0.58
160
1188
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
198
1552
1.29
2.98
1.9
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
235
1883
1.27
2.97
4.0
3.9
ng/l
94.6
93.7
0.05
209
1645
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
31
162
1.92
2.94
2.1
1.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
100
710
1.42
2.86
4.1
3.2
mmol/l
25.1
24.8
0.27
83
620
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
60
383
1.58
2.86
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
139
1044
1.35
2.84
2.2
1.9
u/l
37.8
38.9
0.26
124
908
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
147
1114
1.34
2.83
5.0
5.4
%
1.8
1.6
1.26
139
1038
(3022313) Gas panel - Capillary blood
159
1219
1.32
2.83
5.0
3.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
39
223
1.76
2.81
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
65
425
1.54
2.80
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
75
507
1.49
2.77
1.6
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
553
4858
1.17
2.74
1.3
1.2
u/ml
1.1
1.7
1.04
158
1282
(3004588) Protein electrophoresis panel - Serum or Plasma
230
1860
1.26
2.71
2.2
2.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
18
79
2.29
2.67
1.8
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
31
168
1.85
2.67
1.2
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2495
24198
1.15
2.63
4.6
4.5
mmol/l
1.4
1.4
4.86
2314
22204
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
563
1.45
2.62
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
65
432
1.52
2.62
1.5
1.4
mmol/l
53.7
60.9
0.85
55
345
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
83
580
1.44
2.61
1.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2512
24381
1.15
2.59
4.7
4.5
mmol/l
4.5
4.6
1.34
2350
22518
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
339
2870
1.20
2.59
1.7
1.8
%
1.5
1.5
0.10
285
2518
(3021960) Folate [Moles/volume] in Serum or Plasma
666
5966
1.15
2.53
1.6
1.6
nmol/l
19.7
20.3
0.53
594
5111
(4015189)
16
69
2.33
2.48
1.4
2.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
39
2.83
2.47
1.2
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
15
63
2.39
2.46
4.3
3.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
46
287
1.61
2.45
1.1
1.1
u/ml
0.4
1.3
1.24
22
125
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
130
1.93
2.45
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
130
1.93
2.45
1.5
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
86
615
1.41
2.41
1.8
1.7
mu/l
292.5
295.0
0.03
74
562
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
27
3.34
2.39
1.2
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
27
3.34
2.39
1.2
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
27
3.34
2.39
1.2
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
47
297
1.59
2.39
1.1
1.1
u/ml
4.1
4.2
0.02
26
151
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
64
2.35
2.38
1.7
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
183
1.76
2.35
1.1
1.0
u/ml
0.2
0.4
—
9
45
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
110
825
1.35
2.33
2.9
3.6
ratio
2.1
2.5
—
6
67
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
262
3118
0.83
2.32
4.9
4.6
%
31.8
32.2
0.27
196
2085
(3004809) Band form neutrophils/100 leukocytes in Blood
66
453
1.47
2.32
2.6
3.6
%
1.2
1.6
0.40
46
347
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
113
852
1.34
2.31
3.1
3.6
mg/l
33.0
72.8
1.56
86
687
(3036603) Volume of Urine
29
162
1.80
2.31
1.7
1.5
ml
2172.4
2001.4
—
10
34
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2413
23413
1.13
2.29
4.2
4.1
mmol/l
1.4
1.3
3.82
2217
21336
(3007930) Methemoglobin/Hemoglobin.total in Blood
142
1108
1.29
2.28
5.1
5.4
%
0.9
0.9
0.58
135
1032
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
373
1.51
2.28
1.8
1.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
13
4.62
2.27
2.2
2.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
23
3.48
2.27
1.4
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
113
855
1.33
2.26
1.3
1.2
u/ml
0.3
0.9
—
10
74
(3021788) Differential panel - Synovial fluid
67
464
1.45
2.26
1.5
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
99
735
1.36
2.25
1.4
1.4
iu/l
29.4
30.3
0.09
78
620
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
29
3.11
2.22
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
52
343
1.52
2.22
1.1
1.1
u/ml
1.4
1.5
0.06
28
143
(3037756) Immunofixation for Serum or Plasma
81
584
1.40
2.20
1.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
137
1071
1.29
2.18
1.3
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
263
2215
1.20
2.16
2.2
2.7
g/l
66.1
66.5
0.52
243
2025
(3022621) pH of Urine by Test strip
199
1630
1.24
2.15
2.9
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
90
665
1.36
2.12
1.8
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2552
24884
1.14
2.11
5.3
5.0
mmol/l
2.7
2.7
0.88
2370
22839
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
60
413
1.46
2.10
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
705
6416
1.13
2.09
3.4
3.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
981
1.30
2.08
2.5
2.4
g/l
10.1
10.3
0.22
107
834
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
76
548
1.40
2.08
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
76
548
1.40
2.08
1.4
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
14
62
2.26
2.07
2.7
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
87
643
1.36
2.06
1.4
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
111
852
1.31
2.04
3.1
3.6
mg/l
46.7
62.8
0.89
83
686
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
144
1145
1.27
2.03
1.9
2.0
ug/l
4.3
2.4
0.60
130
1007
(3024354) Oxygen [Partial pressure] in Venous blood
242
2036
1.20
2.02
3.2
3.1
kpa
4.8
4.6
0.85
233
1963
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
76
2.11
2.02
1.1
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
140
1111
1.27
2.01
2.7
2.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
99
750
1.33
2.00
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
75
544
1.39
1.99
1.8
1.9
iu/l
3.9
4.9
0.34
27
183
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
993
9237
1.11
1.98
4.3
3.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
31
186
1.67
1.97
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
37
235
1.58
1.90
1.2
1.2
u/l
55.1
57.4
0.11
28
159
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
164
1338
1.24
1.87
2.4
2.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
53
367
1.45
1.84
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
55
384
1.44
1.83
2.1
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
1045
1.26
1.83
2.5
2.4
g/l
3.6
3.9
1.96
101
760
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
12
4.17
1.82
1.4
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
1046
1.26
1.81
2.5
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
1047
1.26
1.80
2.5
2.4
g/l
7.2
7.4
0.35
102
798
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
303
1.49
1.80
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
311
2707
1.17
1.78
3.7
4.1
ug/l
44.3
24.6
0.32
257
2227
(1002224) Polysomnography panel
119
942
1.27
1.78
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
880
8179
1.11
1.76
3.5
3.2
mmol/l
7.4
7.7
1.43
743
6868
(3014133) Dog dander IgE Ab [Units/volume] in Serum
36
232
1.56
1.76
1.1
1.1
u/ml
4.2
4.3
0.00
18
82
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
46
313
1.48
1.75
2.2
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
56
397
1.42
1.73
3.2
3.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
123
981
1.26
1.73
2.6
2.4
g/l
3.0
3.1
0.66
101
779
(3029075) Extractable nuclear Ab panel - Serum
13
61
2.14
1.71
1.1
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
42
283
1.49
1.69
2.5
3.5
%
61.4
57.2
0.52
25
174
(4034850)
60
819
0.73
1.68
15.4
10.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
22
126
1.75
1.67
1.0
1.1
iu/ml
9.1
11.8
—
5
40
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
136
1103
1.24
1.67
2.3
1.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
128
1031
1.25
1.67
5.2
3.9
mmol/l
24.9
24.8
0.23
121
959
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
19
3.16
1.66
1.2
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
82
624
1.32
1.66
1.3
1.2
u/ml
5.1
39.9
—
5
33
(3000570) Elastase.pancreatic [Mass/mass] in Stool
94
731
1.29
1.63
1.6
1.5
ug/g
277.9
276.8
0.02
61
437
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
30
189
1.59
1.62
1.3
1.2
titre
115.0
118.5
—
6
39
(3009214) Lutropin [Units/volume] in Serum or Plasma
77
584
1.33
1.60
1.2
1.4
u/l
9.9
9.3
0.13
62
471
(3017446) Testosterone [Moles/volume] in Serum or Plasma
253
2187
1.17
1.60
2.3
2.2
nmol/l
12.3
12.8
0.51
224
1919
(3020874) Milk IgE Ab [Units/volume] in Serum
17
91
1.87
1.60
1.0
1.1
u/ml
1.5
2.0
—
7
30
(3023183) Ammonium ion [Moles/volume] in Plasma
77
585
1.32
1.59
3.5
2.8
umol/l
34.8
36.5
0.23
62
493
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
63
465
1.36
1.57
1.3
1.2
u/ml
1.1
4.4
—
6
34
(3023430) Cat dander IgE Ab [Units/volume] in Serum
32
207
1.55
1.56
1.1
1.1
u/ml
3.4
4.2
0.20
18
81
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
242
2090
1.17
1.56
2.9
2.6
ml/min/173m2
76.1
65.0
1.20
109
846
(21494755) Public health laboratory ask at order entry panel
161
1921
0.83
1.54
1.3
1.4
—
—
—
0
0
(44790047)
44
306
1.44
1.54
1.8
1.5
—
—
—
0
0
(44806118)
44
306
1.44
1.54
1.8
1.5
—
—
—
0
0
(44790049)
44
306
1.44
1.54
1.8
1.5
—
—
—
0
0
(44790048)
44
306
1.44
1.54
1.8
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
84
651
1.30
1.52
1.4
1.5
g/l
0.2
0.2
0.07
77
614
(3012516) Albumin [Mass/volume] in Urine
838
7824
1.10
1.51
3.5
3.3
mg/l
551.9
310.3
0.67
570
5045
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
185
1.57
1.51
1.7
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
87
678
1.29
1.51
1.4
1.5
g/l
1.2
1.2
0.27
81
638
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
170
1.59
1.48
2.0
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
93
734
1.28
1.47
2.7
2.3
g/l
0.0
0.0
0.00
85
679
(3028707) Methadone [Presence] in Urine by Screen method
39
268
1.46
1.46
3.2
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
123
1005
1.23
1.45
2.3
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
52
2.12
1.44
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
76
586
1.30
1.44
1.4
1.2
u/ml
8.6
8.1
0.04
13
91
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
39
2.31
1.43
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
43
303
1.42
1.42
1.3
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
118
1.70
1.41
2.2
2.6
u/ml
868.0
1192.3
0.46
20
118
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
17
289
0.59
1.41
1.2
1.8
—
1098.2
—
0
11
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
32
213
1.51
1.40
1.4
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
102
820
1.25
1.40
2.6
2.2
g/l
38.2
37.7
0.39
93
709
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
89
704
1.27
1.39
1.6
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
93
742
1.26
1.36
2.7
2.3
g/l
0.0
0.0
0.00
85
680
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
5
17
2.94
1.36
1.0
1.7
—
22.5
—
0
10
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
159
1.58
1.34
1.8
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
191
1643
1.17
1.33
3.6
3.3
e9/l
4.2
4.1
0.21
155
1267
(3004119) Hemoglobin [Mass/volume] in Venous blood
191
1644
1.17
1.32
3.3
3.2
g/l
126.3
128.6
0.72
186
1597
(3016650) Hepatitis A virus Ab [Presence] in Serum
52
385
1.36
1.31
1.1
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
149
1258
1.19
1.29
2.6
2.7
%
1.3
1.2
0.22
149
1250
(3020191) Ethanol [Moles/volume] in Serum or Plasma
29
193
1.51
1.29
1.1
1.4
promille
1.2
1.3
0.09
22
148
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
74
579
1.28
1.28
1.4
1.2
u/ml
1.8
3.3
—
10
55
(4133840)
12
62
1.94
1.27
1.5
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
106
1289
0.82
1.27
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
81
642
1.27
1.27
1.9
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
103
840
1.23
1.27
1.6
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
97
786
1.24
1.27
2.7
2.3
g/l
0.1
0.0
0.58
89
721
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
18
107
1.69
1.25
1.0
1.1
iu/ml
316.3
218.4
0.21
18
107
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
42
303
1.39
1.25
1.4
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
87
698
1.25
1.24
2.8
2.6
%
203.6
192.5
0.42
80
664
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(4212803)
6
25
2.40
1.24
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
169
1962
0.85
1.23
1.7
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
58
443
1.32
1.21
1.3
1.2
u/ml
52.4
47.4
—
6
42
(3004616) Nuclear Ab [Presence] in Serum
40
288
1.39
1.21
1.4
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
66
514
1.29
1.20
5.9
5.5
iu/ml
274.7
761.3
0.85
11
73
(3030981) Hyaline casts [#/volume] in Urine by Automated count
161
1382
1.17
1.17
3.5
2.8
e6/l
0.3
0.3
0.10
155
1352
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62
481
1.29
1.17
2.0
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1125
10736
1.07
1.17
5.0
4.9
ug/l
2.7
3.5
0.94
1002
9603
(3025941) Bacteria identified in Stool by Culture
151
1291
1.18
1.16
1.5
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
118
1.61
1.14
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
152
0.53
1.14
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
152
0.53
1.14
1.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
12
65
1.85
1.13
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
41
301
1.37
1.12
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
168
1454
1.16
1.12
1.2
1.3
au/ml
64.7
56.1
—
5
62
(3024522) Salmonella sp identified in Specimen by Organism specific culture
41
302
1.36
1.10
1.4
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
31
2.26
1.10
1.9
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
31
2.26
1.10
1.1
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
69
548
1.26
1.10
3.2
3.2
nmol/l
0.8
0.8
0.09
57
427
(3012898) Urea [Moles/volume] in Urine
5
21
2.38
1.09
1.2
1.2
mmol/l
212.6
146.4
—
5
16
(3045142) Bone marrow Pathology biopsy report
41
303
1.36
1.09
1.2
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
22
144
1.53
1.08
2.5
2.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
19
120
1.59
1.08
3.2
2.9
mu/l
33.1
19.9
0.72
19
115
(3020682) Albumin/Creatinine [Ratio] in Urine
870
8246
1.08
1.08
4.3
4.0
mg/mmol
8.0
9.0
0.39
586
5288
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
32
2.19
1.08
3.9
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
32
2.19
1.08
1.4
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
43
322
1.34
1.06
1.3
1.6
%
65.7
60.7
0.39
30
203
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
113
1.60
1.05
1.9
1.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
22
2.27
1.03
1.2
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
22
2.27
1.03
1.6
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
31
221
1.41
1.02
2.4
2.8
%
11.8
11.2
0.23
31
221
(36660697) Celiac disease serology panel - Serum
195
1720
1.14
1.02
1.1
1.2
—
—
—
0
0
(4024509)
15
239
0.63
1.02
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
200
1769
1.14
1.01
1.4
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
48
369
1.31
1.00
1.5
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
35
2.00
1.00
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
131
1.53
0.99
3.7
2.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
39
291
1.34
0.99
6.9
7.1
mmol/l
7.1
7.4
0.33
29
245
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.3
u/l
2.6
15.3
—
5
23
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
100
840
1.20
0.97
1.7
1.7
mg/l
2.8
4.1
0.75
76
591
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
140
1.50
0.97
1.4
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
140
1.50
0.97
1.4
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
140
1.50
0.97
1.4
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
140
1.50
0.97
1.4
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
84
694
1.22
0.97
1.9
2.3
ug/min
101.6
103.4
0.02
43
430
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
92
1.63
0.97
2.6
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
116
1.55
0.96
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
79
650
1.22
0.95
3.2
3.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
106
900
1.18
0.93
3.1
2.5
g/l
1.0
1.2
0.24
92
778
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
175
1.43
0.92
1.5
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
39
295
1.33
0.92
1.4
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
182
1612
1.14
0.92
2.2
2.4
au/ml
13.8
22.1
—
6
85
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
159
1.45
0.91
1.9
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
86
1.63
0.90
1.3
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
125
1079
1.17
0.90
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
900
8593
1.07
0.90
4.5
4.3
%
22.8
22.0
0.91
419
4167
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88
739
1.20
0.88
1.6
1.6
iu/ml
0.2
8.9
0.57
19
154
(21494890) Protein electrophoresis panel - 24 hour Urine
38
289
1.32
0.88
1.6
2.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
43
1.86
0.87
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
30
2.00
0.87
1.0
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
76
631
1.21
0.86
1.4
1.7
e6/l
26287.2
14195.4
0.80
46
447
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
87
1028
0.84
0.85
1.5
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
145
1.45
0.84
1.6
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
230
1.35
0.84
2.5
2.3
e9/l
1.1
1.1
0.14
18
133
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
31
1.94
0.84
3.2
2.6
u/field
0.3
0.7
—
6
31
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
31
1.94
0.84
2.0
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
45
1.78
0.84
7.1
7.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
50
398
1.26
0.83
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
20
138
1.45
0.81
1.5
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
75
627
1.20
0.81
1.1
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
172
1.40
0.80
2.5
2.1
%
11.9
14.0
0.41
12
72
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
147
1.43
0.80
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
164
1.41
0.79
2.6
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
174
1555
1.13
0.79
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
114
1.49
0.79
1.2
1.2
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
24
0.00
0.79
0.0
1.6
—
0.4
—
0
16
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
173.3
—
0
12
(44806071)
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
157
1395
1.13
0.79
1.2
1.2
iu/ml
61.8
146.8
5.14
57
499
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
48
1.67
0.78
1.3
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
48
1.67
0.78
1.3
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
90
768
1.18
0.78
2.6
2.3
%
91.3
90.1
0.16
82
726
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
90
1.56
0.78
4.6
2.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
35
269
1.30
0.77
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
59
1.70
0.75
17.4
7.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
83
706
1.18
0.75
1.3
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
71
596
1.20
0.75
1.2
1.1
u/ml
1.7
6.9
1.65
11
60
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
75
1.60
0.74
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
75
1.60
0.74
2.8
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
54
1.67
0.74
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
38
298
1.28
0.73
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
38
298
1.28
0.73
1.4
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
142
1.41
0.72
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
110
0.54
0.72
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
21
151
1.39
0.71
3.7
2.9
ph
7.4
7.4
—
8
48
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
37
291
1.27
0.71
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
52
426
1.22
0.70
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
38
300
1.27
0.70
2.5
4.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
38
300
1.27
0.70
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
637
1.18
0.70
1.9
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
109
956
1.15
0.69
2.3
2.3
ug/l
769.9
521.7
0.36
99
902
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
42
1.67
0.68
1.0
1.0
u/ml
105.2
45.9
—
7
42
(3027273) Bicarbonate [Moles/volume] in Venous blood
146
1307
1.12
0.68
3.9
3.3
mmol/l
25.7
25.2
0.98
141
1266
(1001926) Buprenorphine [Presence] in Urine by Screen method
57
475
1.20
0.67
3.7
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
302
2808
1.08
0.66
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
34
268
1.27
0.65
1.3
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
19
137
1.39
0.64
5.3
6.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
29
1.73
0.64
1.8
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
146
1.37
0.63
1.7
1.6
u/l
9.8
6.9
0.30
13
71
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
480
0.81
0.62
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
108
955
1.14
0.62
2.6
3.0
u/ml
0.3
0.3
0.03
53
536
(3010144) Erythrocytes [#/volume] in Synovial fluid
19
257
0.74
0.62
1.1
1.3
e6/l
337377.0
99674.7
—
9
175
(4146454)
23
301
0.76
0.61
2.8
2.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
53
444
1.20
0.60
2.8
2.1
u/l
3659.2
3496.6
0.03
19
180
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
139
0.65
0.60
1.1
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
165
1.34
0.60
1.1
1.3
mmol/l
11.1
12.4
0.42
11
50
(3036489) Thrombin time
106
939
1.13
0.60
2.5
2.1
s
22.0
21.6
0.18
92
838
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
0.1
—
0
11
(3028433) Virus identified in Specimen by Culture
12
80
1.50
0.59
1.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
40
326
1.23
0.59
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
40
326
1.23
0.59
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
92
809
1.14
0.58
2.1
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
538
1.17
0.58
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
228
1.27
0.58
1.9
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
272
2535
1.08
0.58
1.6
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
35
1.72
0.57
1.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
28
220
1.28
0.57
1.7
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
363
0.80
0.56
1.3
1.2
u/ml
1.9
3.3
—
8
123
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
194
1.29
0.55
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
550
5257
1.06
0.55
4.8
4.0
kg/l
1.0
1.0
1.40
81
775
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
37
1.62
0.55
1.7
2.2
umol/l
14.0
16.8
—
6
37
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
122
0.65
0.54
2.0
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
60
1.50
0.54
1.8
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
50
423
1.18
0.53
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
689
6634
1.05
0.53
1.4
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
196
1.28
0.52
4.4
5.1
u/ml
8.0
47.4
—
5
56
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
96
0.62
0.52
1.0
1.1
miu/ml
1108.7
1677.9
—
6
96
(3027008) Opiates [Presence] in Urine
70
611
1.15
0.51
3.3
2.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
47
554
0.85
0.51
4.3
3.3
mmol/l
7.7
7.6
0.17
47
539
(3043409) Potassium [Moles/volume] in Arterial blood
95
847
1.13
0.51
3.7
4.0
mmol/l
3.8
3.9
1.07
90
788
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
22
170
1.30
0.51
2.0
1.5
g/l
1.0
1.0
0.18
22
170
(3027944) Amphetamines [Presence] in Urine
69
602
1.15
0.51
3.4
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
29
233
1.25
0.51
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
38
315
1.21
0.50
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
65
566
1.15
0.50
3.5
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
70
613
1.15
0.50
3.4
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
30
243
1.24
0.49
2.2
2.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
24
189
1.27
0.49
1.3
1.5
—
73.1
—
0
14
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
108
0.65
0.48
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
23
181
1.27
0.48
1.0
1.1
titre
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
29
355
0.82
0.48
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
69
606
1.14
0.48
3.4
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
17
128
1.33
0.47
1.4
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
111
1.35
0.46
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
164
1.28
0.46
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
21
164
1.28
0.46
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
21
164
1.28
0.46
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
229
2146
1.07
0.45
4.0
3.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
164
0.73
0.45
1.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
34
283
1.20
0.45
1.8
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
67
591
1.14
0.44
2.1
1.9
pmol/l
218.6
204.8
0.49
62
559
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
20
253
0.79
0.44
1.1
1.3
nmol/l
1.3
1.4
0.66
20
227
(3045424) Erythrocytes [Presence] in Urine
48
413
1.16
0.44
1.3
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
69
1.45
0.44
17.4
7.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
52
598
0.87
0.44
1.7
1.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
197
0.76
0.44
1.1
1.0
ng/l
686.0
699.1
—
9
126
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
140
0.71
0.43
1.3
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
74
659
1.13
0.43
1.2
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
27
328
0.82
0.43
1.6
2.0
—
2.9
—
0
8
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
92
0.65
0.42
1.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
32
1.56
0.42
1.0
1.2
umol/24h
1.7
1.9
—
5
32
(3020891) Body temperature
119
1090
1.10
0.42
4.1
4.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
57
1.40
0.42
1.7
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
258
1.20
0.41
4.2
2.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
20
158
1.27
0.41
1.6
1.2
mmol/l
28.9
34.8
0.59
20
139
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
70
1.43
0.41
2.2
1.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(4281824)
18
228
0.79
0.41
1.3
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
3.9
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.2
—
0
10
(1761482) Bacteria [#/volume] in Urine by Culture
59
667
0.88
0.40
5.3
4.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
20
159
1.26
0.40
2.8
2.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
35
1.43
0.39
1.4
1.5
—
—
—
0
0
(3024316) Viscosity of Plasma
0
19
0.00
0.39
0.0
1.4
—
1.9
—
0
10
(3010838) Calcium [Moles/time] in 24 hour Urine
16
124
1.29
0.38
1.5
1.7
—
11.1
—
0
6
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
36
1.39
0.38
3.2
12.6
mmol/l
6.0
6.1
—
5
36
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
1.8
ng/l
184.0
130.8
—
5
36
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.1
ug/l
88.0
73.4
—
5
30
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
68
1.32
0.37
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
24
290
0.83
0.37
1.1
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
179
1.23
0.37
1.6
2.2
e6/l
467.2
686.7
—
10
76
(3015183) Erythrocyte sedimentation rate
14
107
1.31
0.37
1.1
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
299
1.17
0.37
1.3
1.3
mmol/l
8.0
7.4
0.39
28
225
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
161
1.24
0.37
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
161
1.24
0.37
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
161
1.24
0.37
1.3
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
70
1.29
0.36
2.8
2.1
%
204.6
175.0
—
9
65
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
81
1.36
0.36
1.3
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
222
0.81
0.34
1.4
1.4
—
—
—
0
0
(44806420)
6
86
0.70
0.33
3.0
2.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
87
0.69
0.33
2.8
2.4
nmol/l
139.5
151.5
—
6
75
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
413
0.87
0.32
1.0
1.1
iu/ml
6.3
85.2
—
10
90
(3014271) Vancomycin [Susceptibility]
11
143
0.77
0.32
3.6
2.8
—
—
—
0
0
(3004451) EKG impression Narrative
17
137
1.24
0.32
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
140
1313
1.07
0.31
3.7
3.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
52
1.35
0.31
1.4
3.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
7
52
1.35
0.31
1.1
1.2
—
126.0
—
0
9
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
240
1.17
0.30
1.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
240
1.17
0.30
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
240
1.17
0.30
1.3
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
55
1.27
0.30
1.4
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
24
203
1.18
0.29
1.9
1.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
29
250
1.16
0.29
1.3
1.5
%
29.9
29.1
0.04
18
157
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
260
0.85
0.29
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
260
0.85
0.29
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
260
0.85
0.29
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
260
0.85
0.29
1.4
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
316
1.14
0.29
2.0
2.3
mg/l
15.3
25.0
—
10
76
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
112
1.25
0.28
1.8
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
112
1.25
0.28
1.8
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
76
1.32
0.28
1.2
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
76
1.32
0.28
2.0
2.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
214
1.17
0.27
1.2
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
15
183
0.82
0.27
1.7
2.1
ug/l
3.0
3.1
—
10
161
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
116
0.78
0.27
1.3
1.6
ug/l
10.0
9.9
—
9
100
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
120
0.75
0.27
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
29
252
1.15
0.27
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
236
0.85
0.26
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
113
1.24
0.26
3.0
3.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
48
433
1.11
0.26
1.1
1.2
u/ml
212.1
275.5
1.15
30
263
(3004775) Volume in Urine collected for unspecified duration
19
225
0.84
0.26
1.8
2.3
ml
630.0
626.2
0.01
11
145
(3050129) First trimester maternal screen panel - Serum or Plasma
27
310
0.87
0.26
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
214
0.84
0.26
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
214
0.84
0.26
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
138
0.80
0.25
1.8
1.3
nmol/l
134.7
140.5
0.23
11
138
(3033799) Differential panel - Peritoneal fluid
9
75
1.20
0.25
2.2
2.1
—
—
—
0
0
(4198724)
9
75
1.20
0.25
1.3
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
75
1.20
0.25
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
255
1.14
0.24
1.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
82
0.73
0.24
1.2
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
62
571
1.09
0.24
4.3
3.3
u/ml
240.4
1044.6
0.88
55
530
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
15
124
1.21
0.24
2.8
2.1
%
89.7
94.0
0.17
15
117
(1617658) Protocol used for examination of sentinel lymph nodes
14
169
0.83
0.24
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
143
1.19
0.23
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
143
1.19
0.23
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
38
1.32
0.23
4.2
4.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
38
1.32
0.23
3.0
2.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
38
1.32
0.23
6.0
5.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
13
106
1.23
0.23
1.3
1.1
—
13.2
—
0
10
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
136
0.81
0.23
1.2
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
97
1.24
0.23
2.7
1.9
%
133.1
165.5
0.73
12
91
(3010503) CD19 cells [#/volume] in Blood
18
153
1.18
0.22
2.3
2.4
e9/l
0.1
0.3
1.00
18
148
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
41
1.22
0.22
1.0
1.9
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.3
—
1.8
—
0
5
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
14.1
—
0
11
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3018001) Oat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
12
0.00
0.21
0.0
1.2
—
7.7
—
0
12
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
154
1.17
0.21
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
43
1.16
0.21
1.4
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
126
1.19
0.21
1.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
80
1.25
0.20
1.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.2
—
95.7
—
0
14
(3022475) Manganese [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
49
1.22
0.20
1.2
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
49
1.22
0.20
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
14
165
0.85
0.19
1.6
2.1
min
496.3
489.5
—
8
118
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(4094501)
76
715
1.06
0.18
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
59
1.19
0.18
1.1
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
629
6187
1.02
0.17
2.9
3.0
ug/l
0.8
0.8
0.15
415
4126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
50
465
1.08
0.17
1.1
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
47
436
1.08
0.17
1.4
1.4
u/ml
110.6
119.7
—
9
86
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
278
0.90
0.17
1.3
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
68
0.73
0.17
3.8
2.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
68
1.18
0.16
1.0
1.1
%
115.0
101.7
—
8
62
(3013637) Mi-2 Ab [Presence] in Serum
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
61
649
0.94
0.16
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
267
0.90
0.16
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
47
437
1.08
0.16
1.3
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
40
370
1.08
0.15
1.3
1.5
g/l
30.7
32.2
0.29
32
335
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
119
0.84
0.15
15.9
11.1
mmol/l
0.6
0.6
—
10
110
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
224
0.89
0.15
1.1
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
31
338
0.92
0.15
2.6
2.5
mmol/l
4.1
4.1
0.14
31
333
(3035285) Chloride [Moles/volume] in Venous blood
31
338
0.92
0.15
2.6
2.5
mmol/l
105.1
105.5
0.23
31
333
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
159
1.13
0.15
1.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
19
169
1.13
0.14
1.1
1.0
mg/l
326.1
297.1
0.20
13
145
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
84
1.19
0.14
1.3
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
84
1.19
0.14
1.3
2.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
99
0.81
0.13
1.1
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
100
0.80
0.13
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
128
0.86
0.13
7.3
13.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
76
725
1.05
0.13
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
138
0.87
0.13
4.6
3.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
539
5466
0.98
0.12
1.8
1.7
pmol/l
52232572.0
28045438.5
0.35
448
4532
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
79
756
1.05
0.12
1.8
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
355
0.93
0.12
1.4
1.2
u/ml
2.2
5.0
2.31
16
156
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
99
953
1.04
0.12
2.8
3.4
u/ml
6171.6
4454.6
0.10
87
817
(3019225) pH of Specimen
260
2545
1.02
0.12
5.0
4.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
52
492
1.06
0.12
1.6
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
95
1.16
0.11
2.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
95
1.16
0.11
2.3
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
328
3225
1.02
0.11
9.9
7.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
27
251
1.08
0.10
1.2
1.3
u/l
526.1
350.6
0.33
27
242
(4211845)
14
125
1.12
0.10
3.0
3.2
—
—
—
0
0
(3035880) pH of Pleural fluid
17
154
1.10
0.10
1.1
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
43
453
0.95
0.10
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
145
1414
1.03
0.10
1.5
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
45
1.11
0.09
1.0
1.2
nmol/l
47.8
33.9
—
5
33
(4268621)
22
238
0.92
0.09
2.3
2.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
49
467
1.05
0.09
1.2
1.2
u/l
41.3
41.2
0.00
39
402
(3024869) Neuronal Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
51
487
1.05
0.09
1.4
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
11
124
0.89
0.09
1.1
6.9
—
55.1
—
0
36
(3035933) Granulocytes/100 leukocytes in Blood
6
54
1.11
0.09
1.0
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
329
0.94
0.09
2.6
2.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
214
1.08
0.08
1.6
1.5
pmol/l
100.6
193.6
—
6
71
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
19
175
1.09
0.08
1.1
1.1
mg/l
48.0
42.0
0.15
12
145
(3024263) Appearance of Synovial fluid
16
146
1.10
0.08
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
21
195
1.08
0.08
2.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
31
293
1.06
0.08
1.2
1.0
u/ml
1.4
2.4
1.30
17
118
(3023410) Appearance of Cerebral spinal fluid
26
244
1.07
0.08
1.8
1.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
67
1.04
0.08
1.3
1.2
%
119.7
111.2
—
7
58
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
68
1.03
0.07
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
133
0.90
0.07
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
70
0.86
0.07
1.2
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
75
0.80
0.07
1.3
1.3
ug/l
8.7
9.1
—
6
75
(3042733) HLA Ab [Presence] in Serum
8
78
1.03
0.07
4.0
5.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
81
0.86
0.07
1.0
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
80
0.87
0.07
1.3
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
83
0.84
0.07
1.1
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
846
8408
1.01
0.07
2.9
2.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
57
551
1.04
0.06
4.5
3.6
mg/l
30.1
28.2
0.15
37
356
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
216
1.07
0.06
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
16
172
0.93
0.06
1.8
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
92
900
1.02
0.05
2.4
3.3
g/l
0.3
0.3
0.32
42
373
(3016228) CD19 cells/100 cells in Blood
11
100
1.10
0.05
2.4
2.1
%
6.1
10.0
1.16
11
95
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
100
1.10
0.05
1.4
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
159
1.07
0.05
3.2
2.7
%
31.6
38.9
—
7
55
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
110
0.91
0.05
1.6
2.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
221
0.95
0.04
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
57
584
0.98
0.04
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
442
0.97
0.03
2.3
3.4
—
—
—
0
0
(4027681)
14
131
1.07
0.03
1.4
1.2
—
—
—
0
0
(4306422)
36
349
1.03
0.03
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
26
251
1.04
0.02
1.7
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
56
550
1.02
0.02
1.2
1.7
nmol/l
1.1
0.8
1.13
48
454
(3045788) Cell count panel - Pleural fluid
27
262
1.03
0.02
1.6
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
52
529
0.98
0.02
1.5
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
34
332
1.02
0.01
1.4
1.4
e6/l
2682.0
1674.5
0.33
21
233
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
352
1.02
0.01
1.1
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
227
0.97
0.01
1.9
1.9
u/field
4.3
2.1
0.69
14
86
(3012441) Differential panel - Pleural fluid
30
293
1.02
0.01
1.4
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
293
1.02
0.01
1.4
1.4
e6/l
27977.7
90028.5
1.13
13
174
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
26
255
1.02
0.00
1.2
1.5
nmol/l
0.4
0.3
0.33
17
195
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
16
159
1.01
0.00
1.3
1.3
—
72.0
—
0
15
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
53
535
0.99
0.00
1.5
1.3
miu/ml
227.7
216.7
0.07
22
221
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
136
1.03
0.00
1.1
1.1
u/l
1.0
1.1
—
8
76
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.5
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
108
1.02
0.00
1.5
2.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
544
0.99
0.00
1.5
1.5
e6/l
22.9
24.6
0.04
42
426
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
544
0.99
0.00
1.6
1.5
e6/l
13829.5
901.0
0.56
43
446
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
158
1.01
0.00
1.3
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
13
133
0.98
0.00
17.8
12.9
nmol/l
888.8
808.9
0.25
13
127
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
163
0.98
0.00
1.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
71
0.99
0.00
1.9
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
53
0.94
0.00
1.4
1.3
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
79
1.01
0.00
2.6
2.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
60.0
—
0
6
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2984.0
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
95
0.95
0.00
1.2
1.3
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
3.4
—
0
5
(3022689) Creatine [Moles/volume] in Urine
6
63
0.95
0.00
1.0
1.5
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
1136.5
—
0
6
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
57
0.88
0.00
1.4
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
49
1.02
0.00
1.0
1.9
mmol/l
1.2
1.2
—
5
49
(40768446) Kidney Pathology biopsy report
9
98
0.92
0.00
1.8
1.6
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
6.6
—
0
5
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_EAR_RESP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_EAR_RESP | 1.387 [1.24, 1.55] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.056 |
During the follow-up period (1.1.1998 — 31.12.2019), 1065 out of 5721 females with CD2_BENIGN_EAR_RESP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_EAR_RESP | 1.589 [1.44, 1.76] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1926 out of 7557 males with CD2_BENIGN_EAR_RESP died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_EAR_RESP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.112% | 0.271% |
| 5 | 0.805% | 1.641% |
| 10 | 1.946% | 4.303% |
| 15 | 3.24% | 7.829% |
| 20 | 5.823% | 12.915% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_EAR_RESP – Benign neoplasm of middle ear and respiratory system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data